Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us Membership Collaborators Partners
OPEN ACCESS

Traditional Chinese herbal medicine plus triple therapy in treating Helicobacter pylori induced chronic atrophic gastritis: a meta-analysis and cumulative meta-analysis

  • Kai Xiong1,
  • Ting-hui Yue1,
  • Tao Yang2,
  • Wen-ting Hu1,
  • Jia Deng1 and
  • Tian-bao Xiao2,*
Gastroenterology & Hepatology Research   2022;4(1):6

doi: 10.53388/ghr2022-03-048

Published online:

 Author information

Citation: Xiong K, Yue TH, Yang T, Hu WT, Deng J, Xiao TB. Traditional Chinese herbal medicine plus triple therapy in treating Helicobacter pylori induced chronic atrophic gastritis: a meta-analysis and cumulative meta-analysis. Gastroenterol & Hepatol Res. 2022;4(1):6. doi: 10.53388/ghr2022-03-048.

Abstract

Objective

To evaluate the benefits of traditional Chinese herbal medicine (TCHM) plus triple therapy (TT) in the management of Helicobacter pylori (H. pylori)-induced chronic atrophic gastritis (CAG).

Methods

A comprehensive access and electronic database search were carried out from inception to June 2020. Prospective randomized trials (TCHM plus TT vs. TT) were selected to assess the eradication rate of H. pylori (ER of H. pylori), clinical symptom relief rate (SRR), treatment-related adverse reactions (TRAR) and 95% confidence intervals (CI) in the meta-analysis and cumulative meta-analysis (CMA). Meta-regression analysis was used to analyze heterogeneity between studies and publication bias.

Results

33 studies contained 3,226 participants were included. Compared with the TT group, TCHM plus TT group showed a significantly higher ER of H. pylori (OR=4.14, 95% CI: 3.21-5.35; P=0.000) and SRR (OR=4.50, 95% CI: 3.59-5.64). Meanwhile, the TRAR of TCHM plus TT remedy was significantly lower than TT monopoly (RR=0.43, 95% CI: 0.29-0.64; P=0.000). The results of the CMA, sorted by publication year, duration of treatment, and sample size, confirmed that combined treatment remedy was superior to TT monopoly in respect of ER of H. pylori and SRR.

Conclusions

The present study obtained reliable and convincing evidence suggesting that TCHM plus TT remedy was efficacious and safe in treating H. pylori-induced CAG.

Keywords

Traditional Chinese herbal medicine, Triple therapy, Helicobacter pylori, chronic atrophic gastritis, Meta-analysis, Cumulative meta-analysis

About this Article

Cite this article
Xiong K, Yue TH, Yang T, Hu WT, Deng J, Xiao TB. Traditional Chinese herbal medicine plus triple therapy in treating Helicobacter pylori induced chronic atrophic gastritis: a meta-analysis and cumulative meta-analysis. Gastroenterol & Hepatol Res. 2022;4(1):6. doi: 10.53388/ghr2022-03-048.
Copy Export to RIS Export to EndNote
Article History
Received Revised Accepted Published
March 30, 2022
DOI http://dx.doi.org/10.53388/ghr2022-03-048